Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Advancing Hepatic Fibrosis Diagnosis Using Magnetic Resonance Elastography and AI
Published on: July 21, 2023
Role of Red Cell Distribution Width to Platelet Ratio in Predicting Hepatic Fibrosis in Chronic Hepatitis B
A Ferdous1, A N Ahmed, S A Rahman
1Dr Afroza Ferdous, Assistant Surgeon, Narayanganj Sadar Upazilla Health Complex, Narayanganj, Bangladesh.
Insights
The Red cell distribution width to platelet ratio (RPR) shows a strong association with hepatic fibrosis in chronic Hepatitis B virus (HBV) patients. This non-invasive marker can aid in assessing liver fibrosis stages in HBV-infected individuals.
Area of Science:
- Hepatology
- Virology
- Clinical Pathology
- Medical Diagnostics
Background:
- Hepatitis B virus (HBV) infection affects over 2 billion people globally, with 400 million chronic carriers at risk of liver cirrhosis and cancer.
- In Bangladesh, HBV prevalence ranges from 2.3% to 9.7%, with approximately 10 million carriers, driven by factors like lack of health education and vaccination.
- Accurate assessment of hepatic fibrosis is crucial for managing chronic HBV infection and preventing severe liver disease.
Purpose of the Study:
- To evaluate the Red cell distribution width to platelet ratio (RPR) as a non-invasive marker for predicting hepatic fibrosis in chronic Hepatitis B virus patients.
- To determine the correlation between RPR and the stages of hepatic fibrosis.
- To assess the diagnostic performance of RPR in identifying hepatic fibrosis.
Main Methods:
- A cross-sectional study involving 40 patients with chronic Hepatitis B virus infection.
- Measurement of Red cell distribution width (RDW) and platelet count using an automated hematology analyzer.
- Calculation of RPR and correlation analysis with histopathologically determined stages of hepatic fibrosis; Receiver-Operating Characteristic (ROC) curve analysis was used.
Main Results:
- A significant positive correlation (Spearman's coefficient = 0.749, p<0.001) was observed between RPR and the stages of hepatic fibrosis in chronic HBV patients.
- The RPR demonstrated a sensitivity of 62.86%, specificity of 80%, positive predictive value of 95.65%, and negative predictive value of 23.53%.
- The area under the ROC curve for identifying hepatic fibrosis using RPR was 0.889, indicating strong diagnostic performance.
Conclusions:
- The Red cell distribution width to platelet ratio (RPR) is strongly associated with the stages of hepatic fibrosis in chronic Hepatitis B patients.
- RPR emerges as a potentially valuable and non-invasive diagnostic tool for assessing hepatic fibrosis in the context of chronic HBV infection.
- Further research with larger cohorts is warranted to validate RPR's utility in clinical practice for managing chronic Hepatitis B.
Abstract:
Hepatitis B virus (HBV) infection is a serious global health problem. Globally more than 2 (Two) billion people are infected with Hepatitis B virus and about 400 million people are chronic carriers who are at risk of death from liver cirrhosis and liver cancer that kill more than one million people globally each year. Prevalence of HBV infection in Bangladesh is 2.3 to 9.7% and approximately 10 million people are harboring the virus as carrier. HBV infection is increasing at an alarming rate in Bangladesh due to lack of health education, poverty, illiteracy and lack of hepatitis B vaccination. This cross sectional study was carried out in the Department of Clinical Pathology, in collaboration with Department of Hepatology and Department of Pathology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, Bangladesh from September 2013 to August 2014 to assess the role of Red cell distribution width to platelet ratio (RPR) as a non invasive marker in predicting hepatic fibrosis in chronic hepatitis B patients. Total 40 patients with chronic hepatitis B virus infection who fulfilled the criteria of chronic hepatitis B were included in this study. In this study, majority of the patients belonged to 20-29 years, most of the patients were male and HBeAg negative .Histopathology was gold standard to identify the stages of hepatic fibrosis. We also measured RDW and Platelet count by automated haematology analyzer when platelet count was rechecked manually; RDW to platelet ratio was calculated to see the correlation between RPR with different stages of hepatic fibrosis. In chronic hepatitis B patients a positive and significant correlation was found between RPR and stages of hepatic fibrosis and Spearman's correlation coefficient for RPR was 0.749 which was positive and highly significant (p<0.001). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of RDW to Platelet ratio (RPR) was 62.86%, 80%, 95.65%, 23.53% and 65% respectively. To assess the diagnostic performance of RPR we also used receiver-operating curve (ROC). The area under ROC was 0.889 for identification of hepatic fibrosis. This data revealed that RPR is strongly associated with stages of hepatic fibrosis in chronic hepatitis B patients. As such RPR may be a useful diagnostic tool for assessing the hepatic fibrosis in chronic hepatitis B patients.
Related Concept Videos
Hepatic Drug Clearance: Role of Transporters
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...

